Clinical features and prognosis of influenza-associated encephalopathy in children

Wen-Wen LIN, Xiao-Jie SONG, Li JIANG

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (8) : 984-990.

PDF(2730 KB)
HTML
PDF(2730 KB)
HTML
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (8) : 984-990. DOI: 10.7499/j.issn.1008-8830.2601200
CLINICAL RESEARCH

Clinical features and prognosis of influenza-associated encephalopathy in children

Author information +
History +

Abstract

Objective To investigate the clinical features, prognosis, and factors associated with influenza-associated encephalopathy (IAE) in children. Methods Clinical data of 186 children hospitalized with influenza and neurological symptoms at the Children's Hospital of Chongqing Medical University from January 2015 to December 2025 were retrospectively analyzed. Based on whether they met the diagnostic criteria for acute encephalopathy, patients were divided into the IAE group and the non-IAE group. Clinical manifestations, laboratory findings, neuroimaging characteristics, treatment, and outcomes were compared between the two groups. Results The IAE group included 58 patients (31.2%), with seizures and persistent disturbance of consciousness as the main neurological manifestations (40 cases each, 69.0%). Compared with the non-IAE group, the IAE group had an older age at onset and higher rates of electroencephalographic and neuroimaging abnormalities (P<0.05), with significantly more frequent involvement of deep brain structures including the thalamus, basal ganglia, and brainstem (P<0.001). In the IAE group, 7 patients (12.1%) died during hospitalization, and 12(20.7%) had neurological sequelae at discharge. At a median follow-up of 12 months, the incidences of motor, language, and cognitive dysfunctions, as well as the rate of poor long-term prognosis, were significantly higher in the IAE group (P<0.05). Multivariable logistic regression analysis showed that older age (OR=1.19) and elevated serum lactate dehydrogenase (OR=1.01) were positively associated with the occurrence of IAE (both P<0.05). Conclusions Pediatric IAE is characterized by seizures and persistent disturbance of consciousness, with a predilection for deep brain structures and a high risk of poor prognosis. Older age and elevated serum lactate dehydrogenase are closely associated with the development of IAE.

Key words

Encephalopathy / Influenza / Prognosis / Child

Cite this article

Download Citations
Wen-Wen LIN , Xiao-Jie SONG , Li JIANG. Clinical features and prognosis of influenza-associated encephalopathy in children[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(8): 984-990 https://doi.org/10.7499/j.issn.1008-8830.2601200

References

[1]
Paules C, Subbarao K. Influenza[J]. Lancet, 2017, 390(10095): 697-708. DOI: 10.1016/S0140-6736(17)30129-0 .
[2]
Antoon JW, Hall M, Herndon A, et al. Prevalence, risk factors, and outcomes of influenza-associated neurologic complications in children[J]. J Pediatr, 2021, 239: 32-38.e5. PMCID: PMC8604779. DOI: 10.1016/j.jpeds.2021.06.075 .
[3]
Wang GF, Li W, Li K. Acute encephalopathy and encephalitis caused by influenza virus infection[J]. Curr Opin Neurol, 2010, 23(3): 305-311. DOI: 10.1097/wco.0b013e328338f6c9 .
[4]
Sun R, Zhang X, Jia W, et al. Analysis of clinical characteristics and risk factors for death due to severe influenza in children[J]. Eur J Clin Microbiol Infect Dis, 2024, 43(3): 567-575. DOI: 10.1007/s10096-024-04759-1 .
[5]
Okuno H, Yahata Y, Tanaka-Taya K, et al. Characteristics and outcomes of influenza-associated encephalopathy cases among children and adults in Japan, 2010-2015[J]. Clin Infect Dis, 2018, 66(12): 1831-1837. PMCID: PMC5982813. DOI: 10.1093/cid/cix1126 .
[6]
关鸿志. 重视副感染脑病的诊治[J]. 中华神经科杂志, 2025, 58(5): 457-461. DOI: 10.3760/cma.j.cn113694-20241221-00811 .
[7]
Frankl S, Coffin SE, Harrison JB, et al. Influenza-associated neurologic complications in hospitalized children[J]. J Pediatr, 2021, 239: 24-31.e1. PMCID: PMC9753480. DOI: 10.1016/j.jpeds.2021.07.039 .
[8]
Sun R, Zhang X, Hou J, et al. Predictive value of IL-6 and lymphocyte subsets for death in children with influenza-associated encephalopathy a retrospective study[J]. Mediators Inflamm, 2024, 2024(1): 5564727. PMCID: PMC11611401. DOI: 10.1155/mi/5564727 .
[9]
Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-dimer[J]. J Am Coll Cardiol, 2017, 70(19): 2411-2420. DOI: 10.1016/j.jacc.2017.09.024 .
[10]
Kang S, Kishimoto T. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms[J]. Exp Mol Med, 2021, 53(7): 1116-1123. PMCID: PMC8273570. DOI: 10.1038/s12276-021-00649-0 .
[11]
Wang H, Zeng L, Cheng X, et al. Elevated D-dimer on admission may predict poor prognosis in childhood influenza associated encephalopathy[J]. Sci Rep, 2025, 15(1): 3122. PMCID: PMC11761501. DOI: 10.1038/s41598-025-87690-5 .
[12]
Wang S, Wang D, Wang X, et al. Cytokine storm related to CD4+ T cells in influenza virus-associated acute necrotizing encephalopathy[J]. Immune Netw, 2024, 24(2): e18. PMCID: PMC11076295. DOI: 10.4110/in.2024.24.e18 .
[13]
Li K, Zhang T, Liu G, et al. Plasma exchange therapy for acute necrotizing encephalopathy of childhood[J]. Pediatr Investig, 2021, 5(2): 99-105. PMCID: PMC8212728. DOI: 10.1002/ped4.12280 .
[14]
Mizuguchi M, Ichiyama T, Imataka G, et al. Guidelines for the diagnosis and treatment of acute encephalopathy in childhood[J]. Brain Dev, 2021, 43(1): 2-31. DOI: 10.1016/j.braindev.2020.08.001 .
[15]
Sakuma H, Thomas T, Debinski C, et al. International consensus definitions for infection-triggered encephalopathy syndromes[J]. Dev Med Child Neurol, 2025, 67(2): 195-207. PMCID: PMC11695768. DOI: 10.1111/dmcn.16067 .
[16]
Ito Y, Ichiyama T, Kimura H, et al. Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy[J]. J Med Virol, 1999, 58(4): 420-425. DOI: 10.1002/(sici)1096-9071(199908)58:4<420::aid-jmv16>3.0.co;2-t .
[17]
Mccall S, Henry JM, Reid AH, et al. Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases[J]. J Neuropathol Exp Neurol, 2001, 60(7): 696-704. DOI: 10.1093/jnen/60.7.696 .
[18]
Mastrolia MV, Rubino C, Resti M, et al. Characteristics and outcome of influenza-associated encephalopathy/encephalitis among children in a tertiary pediatric hospital in Italy, 2017-2019[J]. BMC Infect Dis, 2019, 19(1): 1012. PMCID: PMC6884834. DOI: 10.1186/s12879-019-4636-5 .
[19]
Influenza-Associated Acute Necrotizing Encephalopathy (IA-ANE) Working Group, Silverman A, Walsh R, et al. Influenza-associated acute necrotizing encephalopathy in US children[J]. JAMA, 2025, 334(8): 692-701. PMCID: PMC12311823. DOI: 10.1001/jama.2025.11534 .
[20]
Dale RC, Thomas T, Patel S, et al. CSF neopterin and quinolinic acid are biomarkers of neuroinflammation and neurotoxicity in FIRES and other infection-triggered encephalopathy syndromes[J]. Ann Clin Transl Neurol, 2023, 10(8): 1417-1432. PMCID: PMC10424664. DOI: 10.1002/acn3.51832 .
[21]
Appavu B, Foldes S, Fox J, et al. Treatment timing, EEG, neuroimaging, and outcomes after acute necrotizing encephalopathy in children[J]. J Child Neurol, 2021, 36(7): 517-524. DOI: 10.1177/0883073820984063 .
[22]
Yamamoto H, Okumura A, Natsume J, et al. A severity score for acute necrotizing encephalopathy[J]. Brain Dev, 2015, 37(3): 322-327. DOI: 10.1016/j.braindev.2014.05.007 .
[23]
Fan C, Li F, Li K, et al. High-dose methylprednisolone and tocilizumab improve survival of patients with high-risk pediatric acute necrotizing encephalopathy[J]. Clin Exp Pediatr, 2026, 69(1): 56-64. PMCID: PMC12790894. DOI: 10.3345/cep.2025.01431 .
[24]
Shukla P, Mandalla A, Elrick MJ, et al. Clinical manifestations and pathogenesis of acute necrotizing encephalopathy: the interface between systemic infection and neurologic injury[J]. Front Neurol, 2022, 12: 628811. PMCID: PMC8764155. DOI: 10.3389/fneur.2021.628811 .
[25]
Lee VWM, Khoo TB, Teh CM, et al. Factors associated with outcomes of severe acute necrotizing encephalopathy: a multicentre experience in Malaysia[J]. Dev Med Child Neurol, 2023, 65(9): 1256-1263. DOI: 10.1111/dmcn.15536 .
[26]
Yang M, Yi L, Jia F, et al. Characteristics and outcome of influenza-associated encephalopathy/encephalitis among children in China[J]. Clinics, 2024, 79: 100475. PMCID: PMC11345302. DOI: 10.1016/j.clinsp.2024.100475 .
[27]
Chang HP, Hsia SH, Lin JJ, et al. Early high-dose methylprednisolone therapy is associated with better outcomes in children with acute necrotizing encephalopathy[J]. Children (Basel), 2022, 9(2): 136. PMCID: PMC8870393. DOI: 10.3390/children9020136 .
[28]
Nagase H, Yamaguchi H, Tokumoto S, et al. Timing of therapeutic interventions against infection-triggered encephalopathy syndrome: a scoping review of the pediatric literature[J]. Front Neurosci, 2023, 17: 1150868. PMCID: PMC10477367. DOI: 10.3389/fnins.2023.1150868 .
[29]
Hosie PH, Lim C, Scott TRD, et al. Treatment of severe acute necrotizing encephalopathy of childhood with interleukin-6 receptor blockade in the first 24 h as add-on immunotherapy shows favorable long-term outcome at 2 years[J]. Brain Dev, 2023, 45(7): 401-407. DOI: 10.1016/j.braindev.2023.03.002 .
[30]
Okajima K, Hayakawa I, Tsuboi N, et al. Early therapeutic plasma exchange may lead to complete neurological recovery in moderate to severe influenza-associated acute necrotizing encephalopathy[J]. Brain Dev, 2022, 44(7): 492-497. DOI: 10.1016/j.braindev.2022.03.004 .

Footnotes

所有作者声明无利益冲突。

PDF(2730 KB)
HTML

Accesses

Citation

Detail

Sections
Recommended

/